Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Eoganachton Apr 14, 2022 12:02pm
402 Views
Post# 34604044

Dr. McFarland to Talk Tomorrow

Dr. McFarland to Talk TomorrowIf you happen to be in the Washington DC area tomorrow, Dr McFarland will be giving an hour long talk at the University of Maryland which is open to the public. I'm not sure if it's possible to attend virtually. I emailed Dr. Huang about it. I will post login information if he gets back to me.

BIOE Seminar: Tackling Cancer and Infection with Light-Responsive Molecules

University of Maryland
 
A. James Clark Scool of Engineering
Fischell Department of Engineering
 
Friday, April 15, 2022
9:00 a.m.-10:00 a.m.
A. James Clark Hall, Room 2121
 
Joe Huang
hchuang@umd.edu
 
About the speaker: 
 
Sherri McFarland's research interests include translational drug discovery for cancer and infection, coordination complexes, metallodrugs and medicinal inorganic chemistry, photodrugs and photomedicine, photodynamic therapy (PDT), photochemotherapy (PCT), photoactivated chemotherapy (PACT), phototherapy, photochemistry and photophysics, chemical synthesis, chemical biology, immunomodulators and immunomodulating therapies, photosensitizing natural products, photodynamic inactivation (PDI). 
 
Abstract: 
 
Photomedicine is an interdisciplinary field where chemistry and light meet to fight disease. Photodynamic therapy (PDT) is a special branch of photomedicine that employs a sensitizer molecule, light, and oxygen to destroy target cells with spatiotemporal selectivity. Using a multidisciplinary approach, we have introduced both synthetic compounds and natural products as photosensitizers for PDT. Both have successfully completed Phase 1 clinical trials and are currently in Phase 2 clinical trials. This seminar will share some of our stories in developing metallodrug photosensitizers for treating bladder cancer and photoactive plant extracts for improving oral health. If time permits, some new directions will be highlighted.
 
Audience: Public 
<< Previous
Bullboard Posts
Next >>